Evidence map›Paper›PMID 36688616›Full record

ArticleThe Analyst2023

A comparative study of aptamer isolation by conventional and microfluidic strategies.

Xin Meng, Kechun Wen, Marimuthu Citartan, Qiao Lin

Abstract readComparative Study
In one paragraph

Article in The Analyst, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Aptamer targeting proprotein convertase subtilisin/kexin type 9:Research in pharmaceutical sciences · 2026
    Article
  2. Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.Radiation (Multidisciplinary Digital Publishing Institute) · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xin MengDepartment of Mechanical Engineering, Columbia University, New York, NY, 10027, USA. qlin@columbia.edu.ORCID http://orcid.org/0000-0001-8146-3186
Kechun WenDepartment of Mechanical Engineering, Columbia University, New York, NY, 10027, USA. qlin@columbia.edu.ORCID http://orcid.org/0000-0002-4470-6692
Marimuthu CitartanDepartment of Mechanical Engineering, Columbia University, New York, NY, 10027, USA. qlin@columbia.edu.ORCID http://orcid.org/0000-0001-5395-0040
Qiao LinDepartment of Mechanical Engineering, Columbia University, New York, NY, 10027, USA. qlin@columbia.edu.

Funding

Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FORNACE, ALBERT J · 2005 to 2024
$105.4M
Towards rapid measurement of antibiotics in critical care settingR01EB032910 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CREMERS, SERGE, LIN, QIAO · 2022 to 2025
$2.7M
Analog-based Approaches to Isolation of Aptamers for Challenging TargetsR01GM138843 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STOJANOVIC, MILAN N · 2020 to 2023
$2.3M
A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic MalignanciesR21CA261775 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIN, QIAO · 2022 to 2024
$599k
NCI NIH HHS R21 CA261775NIAID NIH HHS U19 AI067773NIBIB NIH HHS R01 EB032910NIGMS NIH HHS R01 GM138843
6 · The paper itself

Abstract

Aptamers are single-stranded oligonucleotide molecules that bind with high affinity and specificity to a wide range of target molecules. The method of systematic evolution of ligands by exponential enrichment (SELEX) plays an essential role in the isolation of aptamers from a randomized oligonucleotide library. To date, significant modifications and improvements of the SELEX process have been achieved, engendering various forms of SELEX from conventional SELEX to microfluidics-based full-chip SELEX. While full-chip SELEX is generally considered advantageous over conventional SELEX, there has not yet been a conclusive comparison between the methods. Herein, we present a comparative study of three SELEX strategies for aptamer isolation, including those using conventional agarose bead-based partitioning, microfluidic affinity selection, and fully integrated microfluidic affinity selection and PCR amplification. Using immunoglobulin E (IgE) as a model target molecule, we compare these strategies in terms of the time and cost for each step of the SELEX process including affinity selection, amplification, and oligonucleotide conditioning. Target-binding oligonucleotides in the enriched pools are sequenced and compared to assess the relative efficacy of the SELEX strategies. We show that the microfluidic strategies are more time- and cost-efficient than conventional SELEX.

Indexed as

Aptamers, NucleotideMicrofluidicsBase SequenceLigandsPolymerase Chain ReactionSELEX Aptamer TechniqueAptamers, NucleotideLigands

Identifiers

PMID36688616
PMCPMC10143297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.